Literature DB >> 12240944

Pathway of oral absorption of heparin with sodium N-[8-(2-hydroxybenzoyl)amino] caprylate.

Dmitry Malkov1, Huai-Zhen Wang, Steven Dinh, Isabel Gomez-Orellana.   

Abstract

PURPOSE: The oral bioavailability of heparin is negligible. Recent studies, however, have shown that sodium N-[8-(2-hydroxybenzoyl) amino]caprylate (SNAC) and other N-acylated amino acids enable oral heparin absorption. To investigate the mechanism by which heparin crosses the intestinal epithelium in the presence of SNAC, we have used fluorescence microscopy to follow the transport of heparin across Caco-2 cell monolayers.
METHODS: The experiments were carried out on Caco-2 monolayers and Caco-2 cells grown to confluence on culture dishes, using different concentrations of SNAC. The localization of fluorescently labeled heparin was determined using epi-fluorescence and confocal microscopy. DNA dyes were used to determine the effect of SNAC on the plasma membrane integrity. F-actin was labeled with fluorescent phalloidin to investigate the stability of perijunctional actin rings in the presence of SNAC.
RESULTS: Heparin was detected in the cytoplasm only after incubation of the cells with heparin and SNAC. No DNA staining was observed in cells incubated with a DNA dye in the presence of SNAC concentrations at which heparin transport occurred. In addition, no signs of actin redistribution or perijunctional ring disbandment were observed during the transport of heparin.
CONCLUSIONS: The results indicate that SNAC enables heparin transport across Caco-2 monolayers via the transcellular pathway. Heparin transport in the presence of SNAC is selective and does not involve permeabilization of the plasma membrane or tight junction disruption.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12240944     DOI: 10.1023/a:1019802310702

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Regulation of the intestinal epithelial paracellular barrier.

Authors: 
Journal:  Pharm Sci Technolo Today       Date:  1999-07

2.  Transcellular uptake mechanisms of the intestinal epithelial barrier Part one.

Authors: 
Journal:  Pharm Sci Technolo Today       Date:  1999-04

3.  Nuclear envelope permeability.

Authors:  P L Paine; L C Moore; S B Horowitz
Journal:  Nature       Date:  1975-03-13       Impact factor: 49.962

4.  Intestinal absorptive cell tight junctions are linked to cytoskeleton.

Authors:  J L Madara
Journal:  Am J Physiol       Date:  1987-07

Review 5.  Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism.

Authors:  B J Aungst
Journal:  J Pharm Sci       Date:  1993-10       Impact factor: 3.534

6.  Microinjection studies of protein transit across the nuclear envelope of human cells.

Authors:  D W Stacey; V G Allfrey
Journal:  Exp Cell Res       Date:  1984-09       Impact factor: 3.905

7.  Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC)

Authors:  W Klein; A Buchwald; S E Hillis; S Monrad; G Sanz; A G Turpie; J van der Meer; E Olaisson; S Undeland; K Ludwig
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

8.  Acylated non-alpha-amino acids as novel agents for the oral delivery of heparin sodium, USP.

Authors:  A Leone-Bay; D R Paton; B Variano; H Leipold; T Rivera; J Miura-Fraboni; R A Baughman; N Santiago
Journal:  J Control Release       Date:  1998-01-02       Impact factor: 9.776

9.  Functional coupling of tight junctions and microfilaments in T84 monolayers.

Authors:  J L Madara; J Stafford; D Barenberg; S Carlson
Journal:  Am J Physiol       Date:  1988-03

10.  Chemical factors that influence nucleocytoplasmic transport: a fluorescence photobleaching study.

Authors:  L W Jiang; M Schindler
Journal:  J Cell Biol       Date:  1986-03       Impact factor: 10.539

View more
  6 in total

1.  Oral absorption enhancement of cromolyn sodium through noncovalent complexation.

Authors:  Xuan Ding; Parshuram Rath; Robert Angelo; Thomas Stringfellow; Elizabeth Flanders; Steven Dinh; Isabel Gomez-Orellana; Joseph R Robinson
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

Review 2.  A Critical Overview of the Biological Effects of Excipients (Part II): Scientific Considerations and Tools for Oral Product Development.

Authors:  Marilyn N Martinez; Fang Wu; Balint Sinko; David J Brayden; Michael Grass; Filippos Kesisoglou; Aaron Stewart; Kiyohiko Sugano
Journal:  AAPS J       Date:  2022-05-02       Impact factor: 4.009

3.  Delivery of therapeutic levels of heparin and low-molecular-weight heparin through a pulmonary route.

Authors:  Yiwei Qi; Ganlin Zhao; Dongfang Liu; Zachary Shriver; Mallik Sundaram; Shiladitya Sengupta; Ganesh Venkataraman; Robert Langer; Ram Sasisekharan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-29       Impact factor: 11.205

4.  Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study.

Authors:  Alyaa Ramadan; Frederic Lagarce; Anne Tessier-Marteau; Olivier Thomas; Pierre Legras; Laurent Macchi; Patrick Saulnier; Jean Pierre Benoit
Journal:  Int J Nanomedicine       Date:  2011-11-21

5.  Oral heparin: status review.

Authors:  Ehud Arbit; Michael Goldberg; Isabel Gomez-Orellana; Shingai Majuru
Journal:  Thromb J       Date:  2006-05-10

Review 6.  Strategies to Overcome Heparins' Low Oral Bioavailability.

Authors:  Ana Rita Neves; Marta Correia-da-Silva; Emília Sousa; Madalena Pinto
Journal:  Pharmaceuticals (Basel)       Date:  2016-06-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.